Christopher Ryan


  • 4657 Citations
  • 37 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • Research Output

    Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

    Patel, S., von Mehren, M., Reed, D. R., Kaiser, P., Charlson, J., Ryan, C., Rushing, D., Livingston, M., Singh, A., Seth, R., Forscher, C., D'Amato, G., Chawla, S. P., McCarthy, S., Wang, G., Parekh, T., Knoblauch, R., Hensley, M. L., Maki, R. G. & Demetri, G. D., Aug 1 2019, In : Cancer. 125, 15, p. 2610-2620 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

    Tap, W. D., Gelderblom, H., Palmerini, E., Desai, J., Bauer, S., Blay, J. Y., Alcindor, T., Ganjoo, K., Martín-Broto, J., Ryan, C., Thomas, D. M., Peterfy, C., Healey, J. H., van de Sande, M., Gelhorn, H. L., Shuster, D. E., Wang, Q., Yver, A., Hsu, H. H., Lin, P. S. & 3 others, Tong-Starksen, S., Stacchiotti, S. & Wagner, A. J., Aug 10 2019, In : The Lancet. 394, 10197, p. 478-487 10 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations

    Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

    Davis, L., Bolejack, V., Ryan, C., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jun 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

    Research output: Contribution to journalArticle

  • 8 Scopus citations

    Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis

    Sun, M., Marconi, L., Eisen, T., Escudier, B., Giles, R. H., Haas, N. B., Harshman, L. C., Quinn, D. I., Larkin, J., Pal, S. K., Powles, T., Ryan, C., Sternberg, C. N., Uzzo, R., Choueiri, T. K. & Bex, A., Jan 1 2018, (Accepted/In press) In : European Urology.

    Research output: Contribution to journalArticle

  • 19 Scopus citations

    ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas

    Lu, E. & Ryan, C., Jan 1 2018, (Accepted/In press) In : Annals of Surgical Oncology.

    Research output: Contribution to journalArticle